What move does the options market price into Janux Therapeutics's report?

Implied ±22.2%, either direction.

How often does Janux Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

JANXNasdaqPharmaceutical Preparations

Janux Therapeutics, Inc. (JANX) earnings date, market-implied expected move, and options open interest by expiry

17.85

+0.02 · +0.14%

post 18.15 +1.69%

After hours15:59 ETdelayed

Open18.00Volume769,312Mkt cap$1.1BEPS-1.64

Day17.53 – 18.1698%52-wk12.12 – 35.3426%

JANX

Janux Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±22.2%implied · straddle

13.8721.77

spot 17.82exp Nov 20ATM strike 17.5ATM straddle 4.65IV 154%

Nov 3 close

Expected move

Inputs

Next report

Nov 5

after close · in 1 day

est.Q3 FY26

Calendar

Next report

Last report

−1.55%

vs ±10.7% implied · ×0.14

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

1dMRK · customerMerck Initiates Phase 3 Study Evaluating Ohtuvayre® (ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care With a History of Exacerbations

News

Largest filed tie

13F top-10 QoQ

+14.57%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

196 managers

Top fund weight

0.28%

JANX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Janux Therapeutics (JANX) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±13.8%
avg realized: ±2.7%

Nov 6 '24Nov 6 '24confirmed±17.2%▼−1.24%×0.07

Feb 27 '25Feb 27 '25confirmed±16.0%▲+2.75%×0.17

May 8 '25May 8 '25confirmed±10.4%▼−3.07%×0.30

Aug 7 '25Aug 7 '25confirmed±12.6%▲+1.11%×0.09

Q3 FY25Nov 6 '25confirmed±21.6%▼−7.61%×0.35

Q1 FY26Feb 26 '26confirmed±12.2%▼−1.38%×0.11

May 7 '26May 7 '26confirmed±9.4%▼−2.51%×0.27

Q2 FY26Aug 6 '26confirmed±10.7%▼−1.55%×0.14

quarterimplied−25%0+25%realized×

Q2 FY26±10.7%▼−1.55%×0.14

May '26±9.4%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 29 close

0.40OI · 4 expiries · Oct 29 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

728+38%Nov 2016d1,816+88%

1,349−1%Dec 1844d0.891,5210%0.89

1,919+27%Jan 1572d1.861,033+8%1.86

1,403+21%Feb 19107d2.815000%2.81

ExpiryPutsCallsP/C

Nov 2016d728+38%1,816+88%0.40

Dec 1844d1,349−1%1,5210%0.89

Jan 1572d1,919+27%1,033+8%1.86

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±22.2%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−214.01%as filednet margin · revenue +175.03% QoQ

Revenue$10M+175.03%

Gross profit$10M100.00%+175.03%

Operating income−$32M−308.66%+7.37%

Pre-tax income−$22M+9.81%

Net income−$22M−214.01%+9.81%

Cost of revenue$0—

Operating expenses$42M+10.57%

Other income$10M−1.36%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

PCE ×0.82· ±2.8% vs ±3.4% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±2.8%10 of 19×0.82

PPIproducer prices±2.8%5 of 10×0.81

GDPgross domestic product±2.6%12 of 19×0.78

CPROFcorporate profits±2.5%7 of 12×0.73

FOMCrate decision±2.4%9 of 24×0.70

NFPjobs report±2.1%3 of 10×0.63

CPIconsumer prices±1.6%5 of 10×0.48

Bar = avg |move| to ±4% · tick = ±3.4% avg day · ×base = |move| ÷ ±3.4% · min 6 releases

Earnings history

EPS -0.35 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.35	—
Q1 FY26	Feb 26 '26 · confirmed	-0.39	—
Q3 FY25	Nov 6 '25 · confirmed	-0.39	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod